Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Hui Hu

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Journal of Molecular Endocrinology|July 13, 2026
Novel gain-of-function CLCN2 germline mutation associated with nonclassical lateralizing primary aldosteronismSsu-Ju Fu, Kang-Yung Peng, Ya-Hui Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2020
Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary AldosteronismChieh-Kai Chan, Wei-Shiung Yang, Yen-Hung Lin, et al.
NPJ Genomic Medicine|August 28, 2025
PopPK modeling supports BW band dosing of lacosamide for pediatric epilepsyYue Li, Hong-Li Guo, Lin Fan, et al.
Neurobiology of Disease|July 7, 2025
An elusive causal link between epilepsy and vitamin D in children: More questions than answers? A narrative reviewHong-Li Guo, Xi-Li Sun, Yang-Yang Xu, et al.
JAMA Pediatrics|March 9, 2026
Maternal Acetaminophen Use and Child NeurodevelopmentPei-Chen Lee, Yu-Hsuan Chuang, Ya-Hui Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 7, 2018
Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of AldosteronismKuo-How Huang, Chih-Chin Yu, Ya-Hui Hu, et al.
Molecular and Cellular Biochemistry|July 13, 2025
CAR19-T/NK cell and circular aptamer-drug conjugate (ApDC) combination treatment increases immunotherapy efficacyLing-Qi Kong, Su-Yun Chen, Xu Cui, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 5, 2004
A remarkable ligand orientational effect in osmium-atom-induced blue phosphorescenceJen-Kan Yu, Ya-Hui Hu, Yi-Ming Cheng, et al.
Neurobiology of Disease|January 26, 2025
Unveiling the significance of AKAP79/150 in the nervous system disorders: An emerging opportunity for future therapies?Chen-Chao Chu, Ya-Hui Hu, Gui-Zhou Li, et al.
Translational Psychiatry|March 20, 2024
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance togetherHong-Li Guo, Dan-Dan Wu, Di Fu, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Journal of Molecular Endocrinology|July 13, 2026
Novel gain-of-function CLCN2 germline mutation associated with nonclassical lateralizing primary aldosteronismSsu-Ju Fu, Kang-Yung Peng, Ya-Hui Hu, et al.
The Journal of Clinical Endocrinology and Metabolism|August 25, 2020
Arterial Stiffness Is Associated with Clinical Outcome and Cardiorenal Injury in Lateralized Primary AldosteronismChieh-Kai Chan, Wei-Shiung Yang, Yen-Hung Lin, et al.
NPJ Genomic Medicine|August 28, 2025
PopPK modeling supports BW band dosing of lacosamide for pediatric epilepsyYue Li, Hong-Li Guo, Lin Fan, et al.
Neurobiology of Disease|July 7, 2025
An elusive causal link between epilepsy and vitamin D in children: More questions than answers? A narrative reviewHong-Li Guo, Xi-Li Sun, Yang-Yang Xu, et al.
JAMA Pediatrics|March 9, 2026
Maternal Acetaminophen Use and Child NeurodevelopmentPei-Chen Lee, Yu-Hsuan Chuang, Ya-Hui Hu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 7, 2018
Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of AldosteronismKuo-How Huang, Chih-Chin Yu, Ya-Hui Hu, et al.
Molecular and Cellular Biochemistry|July 13, 2025
CAR19-T/NK cell and circular aptamer-drug conjugate (ApDC) combination treatment increases immunotherapy efficacyLing-Qi Kong, Su-Yun Chen, Xu Cui, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 5, 2004
A remarkable ligand orientational effect in osmium-atom-induced blue phosphorescenceJen-Kan Yu, Ya-Hui Hu, Yi-Ming Cheng, et al.
Neurobiology of Disease|January 26, 2025
Unveiling the significance of AKAP79/150 in the nervous system disorders: An emerging opportunity for future therapies?Chen-Chao Chu, Ya-Hui Hu, Gui-Zhou Li, et al.
Translational Psychiatry|March 20, 2024
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance togetherHong-Li Guo, Dan-Dan Wu, Di Fu, et al.
Pageof 12